Soleno Therapeutics Inc
NASDAQ:SLNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
US |
|
Marathon Digital Holdings Inc
NASDAQ:MARA
|
US |
|
M
|
Metcash Ltd
OTC:MCSHF
|
AU |
|
P
|
Paladin Energy Ltd
DUS:PUR
|
AU |
|
Mahaka Radio Integra Tbk PT
IDX:MARI
|
ID |
|
Biofrontera Inc
NASDAQ:BFRI
|
US |
|
Beacon Lighting Group Ltd
ASX:BLX
|
AU |
|
Moncler SpA
MIL:MONC
|
IT |
|
S
|
Sharc International Systems Inc
CNSX:SHRC
|
CA |
|
Amcor PLC
OTC:AMCCF
|
UK |
|
Majestic Gold Corp
XTSX:MJS
|
CA |
|
Radcom Ltd
NASDAQ:RDCM
|
IL |
|
I
|
Icade SA
OTC:CDMGF
|
FR |
|
PTT Global Chemical PCL
OTC:PCHUY
|
TH |
|
B
|
B2Gold Corp
F:5BG
|
CA |
|
Paladin Energy Ltd
ASX:PDN
|
AU |
|
Marfrig Global Foods SA
BOVESPA:MRFG3
|
BR |
|
W
|
Weibo Corp
HKEX:9898
|
CN |
|
S
|
SCG Construction Group JSC
VN:SCG
|
VN |
Wall St Price Targets
SLNO Price Targets Summary
Soleno Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SLNO's stock price target?
Price Target
57.53
USD
According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.
What is the Revenue forecast for Soleno Therapeutics Inc?
Projected CAGR
75%
Over the last 12 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 75%.
What is the Operating Income forecast for Soleno Therapeutics Inc?
Projected CAGR
307%
The compound annual growth rate for Operating Income over the next 3 years is 307%.
What is the Net Income forecast for Soleno Therapeutics Inc?
Projected CAGR
188%
The compound annual growth rate for Net Income over the next 3 years is 188%.
